Nirali N Shah

机构：National Institutes of Health, National Cancer Institute

发表论文 1 篇 · 总被引 9 次 · h-index 1

代表论文

• A phase 1/2 study of donor-derived anti-CD33 CAR T-cell therapy (VCAR33) for relapsed/refractory AML after allogeneic HCT (2026 · Blood · 被引 9)